The pharmaceutical landscape is undergoing a revolution with the emergence of novel glucagon-like peptide-1 (GLP-1) receptor agonists. These innovative drugs demonstrate immense potential in managing type 2 diabetes https://mollylnmm957772.wikipowell.com/6408204/novel_glp_1_receptor_agonists_retatrutide_cagrillintide_tirzepatide_and_semaglutide